Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danbai granules for sequelae of pelvic inflammatory disease
ChiCTR2200063500Phase 4Recruiting
- Sponsor
- Yueyang Hospital of Integrated Traditional Chinese and Western Medicine
- Start
- Jul 2022
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of danbai granules in Pelviabdominal infection (2 arms), sponsored by Yueyang Hospital of Integrated Traditional Chinese and Western Medicine. Primary endpoints: Ultrasound/MRI, Pain Visual Analogue Scale score and 2 more. Started Jul 2022; status: recruiting.
02
Drugs
danbai granules
03
Conditions
Pelviabdominal infection
Beyond the preview
Go deeper on ChiCTR2200063500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063500.